Related Experiment Video
Updated: Apr 28, 2026
09:30
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
2.1K
Prenatal chromosomal microarray for the Catholic physician.
1Geisinger Health System, Danville, PA, USA.
The Linacre Quarterly
|June 6, 2014
Summary
Prenatal chromosomal microarray (CMA) offers new hope for detecting fetal genetic defects, enabling early intervention. However, this advanced genetic testing also raises bioethical considerations that require careful guidance for expectant parents.
Area of Science:
- Genetics
- Prenatal Diagnostics
- Bioethics
Background:
- Chromosomal microarray (CMA) is an established diagnostic tool in pediatrics.
- CMA is increasingly being adopted for prenatal genetic analysis.
- This technology holds promise for identifying fetal genetic abnormalities early.
Purpose of the Study:
- To provide guidance on prenatal genetic testing options.
- To address the bioethical issues associated with prenatal CMA.
- To support healthcare providers offering genetic counseling during pregnancy.
Main Methods:
- Review of current literature on prenatal CMA.
- Analysis of bioethical implications of prenatal genetic diagnostics.
- Synthesis of recommendations for genetic counseling.
Main Results:
- Prenatal CMA can detect a range of genetic disorders.
- Implementation of CMA in prenatal settings necessitates ethical deliberation.
- Counseling is crucial for informed decision-making regarding genetic tests.
Conclusions:
- Prenatal CMA presents significant diagnostic potential for fetal genetic conditions.
- Addressing bioethical concerns is paramount for responsible implementation.
- This paper serves as a resource for genetic counseling in prenatal care.
